Squamous Cell Carcinoma of the Anal Canal: Case Report

Marouane Mountassir

doi:10.58372/2835-6276.1230

Authors

Marouane Mountassir

DOI:

https://doi.org/10.58372/2835-6276.1230

Abstract

-

References

Cancer du canal anal | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d’oncologie digestive (

Machalek DA, Pointen M, Jin F, Fairley C, Farnsworth A, Garland S, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncology. Elsevier Ltd; 2012 Apr 25;13(5):487-500.

Abramowitz L, Jacquard A-C, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, et al. Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer. 2011 Jul;129(2):433–9.

Moureau-Zabotto L., Abramowitz L., Borg C., Francois E., Goere D., Huguet F., Vendrely V., Peiffert D., Siproudhis L., « Cancer du canal anal ». Thésaurus National de Cancérologie Digestive, 11-2016, [En ligne] http://www.tncd.org 6.1.

Glynne-Jones R, Nilsson PJ, Aschele C, Goh V, Peiffert D, Cervantes A, et al. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. European Journal of Surgical Oncology. 2014 Sep 30;40(10):1165–76.

Nigro ND, Vaitkevicius VK, Considine BJ. Combined therapy

Vinayan A, Glynne-Jones R. Anal cancer –What is the optimum chemoradiotherapy? Best Pract Res Clin Gastroenterol. 2016 Aug;30(4):641–53.

Goere D, Bonnet S, Pocard M, Deutsch E, Lasser P, Elias D. Oncologic and functional results after abdominoperineal resection plus pseudocontinent perineal colostomy for epidermoid carcinoma of the anus. Diseases of the Colon & Rectum. 2009 May;52(5):958–63.

Cancer du canal anal | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d’oncologie digestive

Quéro L, Duval X, Abramowitz L, Cancer de l’anus chez les patients séropositifs pour le VIH, Bulletin du Cancer, Volume 101, Issue 11, November 2014, 1034-9.

Meillan N, Huguet F, Peiffert D. [Follow-up after radiotherapy of anal canal carcinoma]. Cancer Radiother. 2015 Sep 30;19(6-7):610–5.

Sebag-Montefiore D, James R, Meadows H, Begum R, Cunningham D, Northover J, et al. The pattern and timing of disease recurrence in squamous cancer of the anus: Mature results from the NCRI ACT II trial. J Clin Oncol 30, 2012 (suppl; abstr 4004).

Rouquie D, Lasser P, Castaing M, Boige V, Goere D, Pignon J-P, et al. [Complete (R0) resection is the only valid prognostic factor in abdominoperineal resection for recurrent cancer of the anal canal (a consecutive series of 95 patients)]. J Chir (Paris). 2008 Jul;145(4):335–40.

Deutsch E, Lemanski C, Pignon JP, Levy A, Delarochefordiere A, Martel-Lafay I, et al. Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial. Ann Oncol. 11 janv 2013;24(11):2834-8.

Kachnic LA, Tsai HK, Coen JJ, Blaszkowsky LS, Hartshorn K, Kwak EL, et al. RTOG 0529: A Phase 2 Evaluation of Dose-Painted Intensity Modulated Radiation Therapy in Combination With 5-Fluorouracil and Mitomycin-C for the Reduction of Acute Morbidity in Carcinoma of the Anal Canal. Radiation Oncology Biology. Elsevier Inc; 2013 May 1;86(1):27–33.

Julie DR, Goodman KA. Advances in the Management of Anal Cancer. Curr Oncol Rep. 2016 Mar;18(3):20.

Améliorer le dépistage des lésions HPV et la vaccination pour prévenir le cancer anal | vih.org